← Browse by Condition
Medical Condition
colon cancer stage iii
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT06830239 Phase 2
Recruiting
Phase II Study of Neoadjuvant Dostarlimab in Patients With Untreated T3-4N0-2 or Stage III pMMR/MSS Resectable Colon Cancer
Enrollment
10 pts
Location
Belgium
Sponsor
Universitaire Ziekenhuizen KU ...
NCT04907643
Recruiting
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Enrollment
360 pts
Location
United States
Sponsor
Cedars-Sinai Medical Center